Patent details
EP2376070 Title: OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH RELEASE RATES
Basic Information
- Publication number:
- EP2376070
- PCT Application Number:
- PCT/EP/2009/067049
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097993166
- PCT Publication Number:
- WO/2010/079047
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH RELEASE RATES
- French Title of Invention:
- FORMULATION À EFFET RETARD D'OCTRÉOTIDE AVEC UN HAUTE TAUX DE LIBÉRATION CONSTANT
- German Title of Invention:
- OCTREOTID-DEPOTFORMULIERUNG MIT KONSTANT HOHE FREISETZUNGSRATE
- SPC Number:
Dates
- Filing date:
- 14/12/2009
- Grant date:
- 10/08/2016
- EP Publication Date:
- 10/08/2016
- PCT Publication Date:
- 15/07/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/10/2011
- EP B1 Publication Date:
- 10/08/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 14/12/2016
- Expiration date:
- 14/12/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/12/2009
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- AHLHEIM Markus
- Address:
- Switzerland (CH)
2
- Name:
- PETERSEN Holger
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 08171712
- Priority Date:
- 15/12/2008
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 9/00;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|